Are you ready for the next generation of cell expansion?
Be among the first to see it at the joint 12th Biennial ASSCR/AGCTS 2022 Scientific Meeting.
Together with our partner Terumo, we are pleased to announce the launch of Quantum Flex, one of the first systems that enables cell therapy commercialisation from process development through manufacturing.
Some of the features of the new Quantum Flex are:
- Expand both suspension and adherent cell types in a low-stress environment.
- Benefit from minimal seeding requirements.
- Reach clinical yields in a concentrated volume.
- Maintain robust viability and target cell phenotypes.
- Manage scale-down process development to larger production runs with multiple bioreactor sizes.
- Facilitate cGMP compliance and data integrity
We look forward to seeing you at ASSCR/AGCTS 2022!
Booth 15: In Vitro Technologies
Booth 20: Terumo Blood and Cell Technologies
Click here for the Terumo Quantum Flex: https://lnkd.in/gGVNek82
